Literature DB >> 11763379

Electron microscopic evidence of persistent chlamydial infection following treatment.

E Y Bragina1, M A Gomberg, G A Dmitriev.   

Abstract

Chlamydia trachomatis infections of the female and male genital tracts are often asymptomatic and, thus, tend to become persistent. In the persistent state the typical Chlamydia life cycle is arrested and standard antibiotic regimens do not always eradicate this infection. We sought to relate treatment failures in men and women with persistent chlamydial genital tract infections to electron microscopic evidence of chlamydial persistence and with atypical morphological forms of the organism. Of 16 patients with chlamydial persistence following azithromycin treatment, morphological variants of this organism were observed by electron microscopy from one endocervical sample and one male urethral sample. We document the presence of intracellular inclusions containing only reticulate bodies, extracellular monomembrane and polymembrane phagosomes containing elementary bodies and reticulate bodies with abnormal outer membranes in the process of dividing extracellularly. These observations parallel previous in vitro studies of chlamydial persistence under adverse conditions. This capacity of C. trachomatis to undergo atypical morphological alterations in vivo may contribute to its persistence and relative resistance to antibiotics.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11763379     DOI: 10.1046/j.1468-3083.2001.00342.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  15 in total

Review 1.  Evolution to a chronic disease niche correlates with increased sensitivity to tryptophan availability for the obligate intracellular bacterium Chlamydia pneumoniae.

Authors:  Wilhelmina M Huston; Christopher J Barker; Anu Chacko; Peter Timms
Journal:  J Bacteriol       Date:  2014-03-28       Impact factor: 3.490

2.  Inhibition of indoleamine 2,3-dioxygenase activity by levo-1-methyl tryptophan blocks gamma interferon-induced Chlamydia trachomatis persistence in human epithelial cells.

Authors:  Joyce A Ibana; Robert J Belland; Arnold H Zea; Danny J Schust; Takeshi Nagamatsu; Yasser M AbdelRahman; David J Tate; Wandy L Beatty; Ashok A Aiyar; Alison J Quayle
Journal:  Infect Immun       Date:  2011-09-12       Impact factor: 3.441

3.  Interaction of herpes simplex virus type 2 (HSV-2) glycoprotein D with the host cell surface is sufficient to induce Chlamydia trachomatis persistence.

Authors:  J Vanover; J Kintner; J Whittimore; R V Schoborg
Journal:  Microbiology (Reading)       Date:  2010-01-28       Impact factor: 2.777

4.  Chlamydia trachomatis infection induces cleavage of the mitotic cyclin B1.

Authors:  Zarine R Balsara; Shahram Misaghi; James N Lafave; Michael N Starnbach
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

5.  Frequency of spontaneous mutations that confer antibiotic resistance in Chlamydia spp.

Authors:  Rachel Binet; Anthony T Maurelli
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

6.  Live-attenuated influenza viruses as delivery vectors for Chlamydia vaccines.

Authors:  Qing He; Luis Martinez-Sobrido; Francis O Eko; Peter Palese; Adolfo Garcia-Sastre; Deborah Lyn; Daniel Okenu; Claudiu Bandea; Godwin A Ananaba; Carolyn M Black; Joseph U Igietseme
Journal:  Immunology       Date:  2007-04-23       Impact factor: 7.397

Review 7.  Future of human Chlamydia vaccine: potential of self-adjuvanting biodegradable nanoparticles as safe vaccine delivery vehicles.

Authors:  Rajnish Sahu; Richa Verma; Saurabh Dixit; Joseph U Igietseme; Carolyn M Black; Skyla Duncan; Shree R Singh; Vida A Dennis
Journal:  Expert Rev Vaccines       Date:  2018-02-06       Impact factor: 5.217

8.  Induction of the Chlamydia muridarum stress/persistence response increases azithromycin treatment failure in a murine model of infection.

Authors:  R Phillips-Campbell; J Kintner; R V Schoborg
Journal:  Antimicrob Agents Chemother       Date:  2014       Impact factor: 5.191

Review 9.  Membrane vesicle production by Chlamydia trachomatis as an adaptive response.

Authors:  Kyla M Frohlich; Ziyu Hua; Alison J Quayle; Jin Wang; Maria E Lewis; Chau-wen Chou; Miao Luo; Lyndsey R Buckner; Li Shen
Journal:  Front Cell Infect Microbiol       Date:  2014-06-10       Impact factor: 5.293

Review 10.  Treatment challenges for urogenital and anorectal Chlamydia trachomatis.

Authors:  Fabian Yuh Shiong Kong; Jane Simone Hocking
Journal:  BMC Infect Dis       Date:  2015-07-29       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.